fbpx
June 2, 2020

MOMENTUM: Combination Product Shows Promise in Migraine MOMENTUM: Combination Product Shows Promise in Migraine

A new combination product comprising the triptan rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam has shown promising results in the treatment of migraine. In the […]
June 2, 2020

Cannabis Gaining Acceptance as Treatment for Neuropathic Pain? Cannabis Gaining Acceptance as Treatment for Neuropathic Pain?

Experts may be moving toward accepting cannabis as a useful tool to treat neuropathic pain (NP), a recent debate on the topic suggests. During the debate, […]
June 1, 2020

Medtronic’s StealthStation DBS Software Subject of Class I Recall Medtronic’s StealthStation DBS Software Subject of Class I Recall

Medtronic has recalled the auto-registration feature in the StealthStation deep brain stimulation (DBS) software because of inaccuracies during DBS procedures, according to a notice on the […]
June 1, 2020

Telerehabilitation May Be Effective in MS Telerehabilitation May Be Effective in MS

Telerehabilitation is safe and may offer functional benefits comparable to those of outpatient rehabilitation for patients with multiple sclerosis (MS) and impaired mobility. Telerehabilitation also saves […]
June 1, 2020

Constraint Movement Therapy May Boost Neuroplasticity in MS Constraint Movement Therapy May Boost Neuroplasticity in MS

Neuroimaging of patients with progressive multiple sclerosis (MS) shows that physical behavioral change therapy, specifically, constraint-induced movement therapy (CIMT), leads to improvement in neuroplasticity compared to […]
May 29, 2020

Early Extubation Tied to Better Outcome After Stroke Thrombectomy Early Extubation Tied to Better Outcome After Stroke Thrombectomy

The shorter, the better when it comes to time spent on a ventilator for stroke patients who undergo mechanical thrombectomy, new research suggests. A study of […]
May 29, 2020

Nilotinib Is Safe in Moderate and Advanced Parkinson’s Disease Nilotinib Is Safe in Moderate and Advanced Parkinson’s Disease

Although nilotinib is safe and tolerable in patients with moderate or advanced Parkinson’s disease, it may not affect the disease’s symptoms, according to investigators. Nevertheless, other […]
May 29, 2020

No Benefit of 3 Commonly Used Medications in MS Fatigue No Benefit of 3 Commonly Used Medications in MS Fatigue

A new placebo-controlled trial has shown no benefit over placebo of three different drugs commonly used to treat fatigue in patients with multiple sclerosis (MS). The […]
May 29, 2020

Most Adult Epilepsy-Related Deaths Could Be Avoided Most Adult Epilepsy-Related Deaths Could Be Avoided

Almost 80% of epilepsy deaths among adults are potentially avoidable, results of a new study from Scotland suggest. Dr Gashirai Mbizvo The research shows that such […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0